Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

Completed · Phase 3 · Has a placebo group

Conditions studied: Moderate-to-Severe Atopic Dermatitis

In brief

The main purpose of the study was to assess the efficacy and safety of nemolizumab after a 16-week treatment period in adult and adolescent subjects with moderate-to-severe atopic dermatitis (AD) not adequately controlled with topical treatments.

Key facts

Study ID

NCT03989349

Run by

Galderma R&D

People needed

787

Starts

2019-06-30

Expected to finish

2022-09-26

Last updated by the study team

2024-08-14

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Galderma Investigational Site 8893 — Birmingham, Alabama, United States
• Galderma Investigational Site 8866 — Guntersville, Alabama, United States
• Galderma Investigational Site 8808 — Scottsdale, Arizona, United States
• Galderma Investigational Site 8906 — Bell Gardens, California, United States
• Galderma Investigational Site 8905 — Canoga Park, California, United States
• Galderma Investigational Site 8577 — Encinitas, California, United States
• Galderma Investigational Site 8673 — Garden Grove, California, United States
• Galderma Investigational Site 8683 — Los Angeles, California, United States
• Galderma Investigational Site 8907 — Newport Beach, California, United States
• Galderma Investigational Site 8799 — Ontario, California, United States
• Galderma Investigational Site 8745 — Pasadena, California, United States
• Galderma Investigational Site 8658 — San Diego, California, United States
• Galderma Investigational Site 8536 — Santa Ana, California, United States
• Galderma Investigational Site 8820 — Westminster, California, United States
• Galderma Investigational Site 8637 — Farmington, Connecticut, United States
• Galderma Investigational Site 8875 — Delray Beach, Florida, United States
• Galderma Investigational Site 8391 — Hialeah, Florida, United States
• Galderma Investigational Site 8727 — Hialeah, Florida, United States
• Galderma Investigational Site 8523 — Largo, Florida, United States
• Galderma Investigational Site 8719 — Miami, Florida, United States
• Galderma Investigational Site 8656 — Miami, Florida, United States
• Galderma Investigational Site 8704 — Miami, Florida, United States
• Galderma Investigational Site 8706 — Miami, Florida, United States
• Galderma Investigational Site 8203 — Tampa, Florida, United States
• Galderma Investigational Site 8749 — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.